Rockwell Medical (RMTI) executive compensation, 2026 proxy

Mark Strobeck, Ph.D., Chief Executive Officer, was paid $1.9M in 2025, up 45% from $1.3M the year before.

Filed
April 30, 2026
Annual meeting
June 12, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.9M+45% vs prior year
CEO pay in equity
45%$861,772 in awards
CEO Target Bonus
80%Percentage of base salary
CFO Target Bonus
45%Percentage of base salary
Bonus Payout Level
100%Achieved corporate performance percentage

How Ph.D. was paid

$1.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary30%Stock awards32%Option awards13%Non-equity incentive24%All other compensation1%

Named executive officers

ExecutiveTotal
Mark Strobeck, Ph.D.Chief Executive Officer$1,895,472
Jesse NeriChief Financial Officer$828,809
Megan TimminsChief Legal Officer and Secretary$978,159

What changed and why

  • $1.9MCEO total compensation increased to $1,895,472 in fiscal 2025 due to larger equity awards.
  • Named executive officers requested no base salary increase for 2025.
  • 100%Annual non-equity incentive plan payouts were achieved at 100% of target based on corporate goals.
  • Long-term equity incentives included performance-based restricted stock units tied to stock price hurdles.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.